Skip to main content

Table 1 Body and heart weight and biochemical markers

From: Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

Groups/miceWt/wtWt/wt + ATIIDb/dbDb/db + DAPADb/db + ATIIDb/db + ATII + DAPA
Numbers865485
Body weight (g)25.5 ± 125.5 ± 1.541.5 ± 5+42.8 ± 2+38.8 ± 8+45.3 ± 5+
Blood pressure (mmHg)95 ± 5137 ± 5+102 ± 397 ± 3147 ± 3+,*133 ± 2+,*,#
Blood glucose (mg/dl)298 ± 55258 ± 76937 ± 75+607 ± 30+,*874 ± 111+556 ± 57+,&
Blood cholesterol118 ± 25143 ± 5120 ± 10143 ± 22202 ± 77188 ± 35
  1. +p < 0.05 vs wt/wt, *p < 0.05 vs db/db, &p < 0.05 vs db/db + ATII, #p < 0.002 vs db/db + ATII